Drug Profile
HO 0303
Alternative Names: HO-03-03; HO/03/03; TruhealLatest Information Update: 17 Jun 2015
Price :
$50
*
At a glance
- Originator HealOr
- Class Anti-inflammatories
- Mechanism of Action Protein kinase C inhibitors; Protein kinase C stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Chronic wounds; Diabetic foot ulcer
Most Recent Events
- 17 Jun 2015 No recent reports on development identified - Phase-I for Chronic wounds in Israel (Topical)
- 17 Jun 2015 No recent reports on development identified - Phase-II/III for Diabetic foot ulcer in India and USA (Topical)
- 03 Apr 2013 HealOr completes enrolment in its phase II/III trial for Diabetic foot ulcer in USA & India (NCT00926068)